0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy on Neurological Diseases Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-25M7562
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Global Gene Therapy on Neurological Diseases Market Size Status and Forecast 2021 2027

Global Gene Therapy on Neurological Diseases Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-25M7562
Report
September 2021
86 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Market Analysis and Insights: Global Gene Therapy on Neurological Diseases Market

In 2021, the global Gene Therapy on Neurological Diseases market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy on Neurological Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy on Neurological Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy on Neurological Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy on Neurological Diseases market.
Global Gene Therapy on Neurological Diseases Scope and Market Size
Gene Therapy on Neurological Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy on Neurological Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Viral Gene Therapy
Non-viral Gene Therapy

Segment by Application

Hospital
Clinic
Other

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Biogen
Novartis
Sarepta Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy on Neurological Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2016-2027)
2.2 Gene Therapy on Neurological Diseases Growth Trends by Regions
2.2.1 Gene Therapy on Neurological Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy on Neurological Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy on Neurological Diseases Industry Dynamic
2.3.1 Gene Therapy on Neurological Diseases Market Trends
2.3.2 Gene Therapy on Neurological Diseases Market Drivers
2.3.3 Gene Therapy on Neurological Diseases Market Challenges
2.3.4 Gene Therapy on Neurological Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue
3.1.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy on Neurological Diseases Revenue
3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio
3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2020
3.5 Gene Therapy on Neurological Diseases Key Players Head office and Area Served
3.6 Key Players Gene Therapy on Neurological Diseases Product Solution and Service
3.7 Date of Enter into Gene Therapy on Neurological Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy on Neurological Diseases Breakdown Data by Type
4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2022-2027)
5 Gene Therapy on Neurological Diseases Breakdown Data by Application
5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy on Neurological Diseases Market Size (2016-2027)
6.2 North America Gene Therapy on Neurological Diseases Market Size by Type
6.2.1 North America Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy on Neurological Diseases Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy on Neurological Diseases Market Size by Type (2016-2027)
6.3 North America Gene Therapy on Neurological Diseases Market Size by Application
6.3.1 North America Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy on Neurological Diseases Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy on Neurological Diseases Market Size by Application (2016-2027)
6.4 North America Gene Therapy on Neurological Diseases Market Size by Country
6.4.1 North America Gene Therapy on Neurological Diseases Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy on Neurological Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy on Neurological Diseases Market Size (2016-2027)
7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type
7.2.1 Europe Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy on Neurological Diseases Market Size by Type (2016-2027)
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application
7.3.1 Europe Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy on Neurological Diseases Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy on Neurological Diseases Market Size by Application (2016-2027)
7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country
7.4.1 Europe Gene Therapy on Neurological Diseases Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy on Neurological Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type
8.2.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application
8.3.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region
8.4.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy on Neurological Diseases Market Size (2016-2027)
9.2 Latin America Gene Therapy on Neurological Diseases Market Size by Type
9.2.1 Latin America Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy on Neurological Diseases Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy on Neurological Diseases Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy on Neurological Diseases Market Size by Application
9.3.1 Latin America Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy on Neurological Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy on Neurological Diseases Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy on Neurological Diseases Market Size by Country
9.4.1 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type
10.2.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application
10.3.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country
10.4.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction
11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction
11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction
11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2016-2021)
11.3.5 Sarepta Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Viral Gene Therapy
    Table 3. Key Players of Non-viral Gene Therapy
    Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Therapy on Neurological Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Therapy on Neurological Diseases Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Therapy on Neurological Diseases Market Share by Regions (2016-2021)
    Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Therapy on Neurological Diseases Market Share by Regions (2022-2027)
    Table 10. Gene Therapy on Neurological Diseases Market Trends
    Table 11. Gene Therapy on Neurological Diseases Market Drivers
    Table 12. Gene Therapy on Neurological Diseases Market Challenges
    Table 13. Gene Therapy on Neurological Diseases Market Restraints
    Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Therapy on Neurological Diseases Market Share by Players (2016-2021)
    Table 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy on Neurological Diseases as of 2020)
    Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy on Neurological Diseases Product Solution and Service
    Table 21. Date of Enter into Gene Therapy on Neurological Diseases Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Therapy on Neurological Diseases Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Therapy on Neurological Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Therapy on Neurological Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Therapy on Neurological Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Therapy on Neurological Diseases Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Gene Therapy on Neurological Diseases Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Therapy on Neurological Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Therapy on Neurological Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Therapy on Neurological Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Therapy on Neurological Diseases Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Gene Therapy on Neurological Diseases Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Therapy on Neurological Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Therapy on Neurological Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Therapy on Neurological Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Biogen Company Details
    Table 62. Biogen Business Overview
    Table 63. Biogen Gene Therapy on Neurological Diseases Product
    Table 64. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2016-2021) & (US$ Million)
    Table 65. Biogen Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Gene Therapy on Neurological Diseases Product
    Table 69. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Sarepta Therapeutics Company Details
    Table 72. Sarepta Therapeutics Business Overview
    Table 73. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product
    Table 74. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2016-2021) & (US$ Million)
    Table 75. Sarepta Therapeutics Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy on Neurological Diseases Market Share by Type: 2020 VS 2027
    Figure 2. Viral Gene Therapy Features
    Figure 3. Non-viral Gene Therapy Features
    Figure 4. Global Gene Therapy on Neurological Diseases Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Gene Therapy on Neurological Diseases Report Years Considered
    Figure 9. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Gene Therapy on Neurological Diseases Market Share by Regions: 2020 VS 2027
    Figure 12. Global Gene Therapy on Neurological Diseases Market Share by Regions (2022-2027)
    Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Players in 2020
    Figure 14. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy on Neurological Diseases as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2020
    Figure 16. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2016-2021)
    Figure 17. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2022-2027)
    Figure 18. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Gene Therapy on Neurological Diseases Market Share by Type (2016-2027)
    Figure 20. North America Gene Therapy on Neurological Diseases Market Share by Application (2016-2027)
    Figure 21. North America Gene Therapy on Neurological Diseases Market Share by Country (2016-2027)
    Figure 22. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gene Therapy on Neurological Diseases Market Share by Type (2016-2027)
    Figure 26. Europe Gene Therapy on Neurological Diseases Market Share by Application (2016-2027)
    Figure 27. Europe Gene Therapy on Neurological Diseases Market Share by Country (2016-2027)
    Figure 28. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2016-2027)
    Figure 38. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gene Therapy on Neurological Diseases Market Share by Type (2016-2027)
    Figure 46. Latin America Gene Therapy on Neurological Diseases Market Share by Application (2016-2027)
    Figure 47. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2016-2027)
    Figure 48. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2016-2027)
    Figure 54. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Gene Therapy on Neurological Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2016-2021)
    Figure 58. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2016-2021)
    Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2016-2021)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Deep Brain Stimulation DBS Devices Market Insights and Forecast to 2028
Global Deep Brain Stimulation (DBS) Devices Market Insights and Forecast to 2028

Deep brain stimulation DBS is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator sometimes referred to as a brain pacemaker which sends electrical impulses through implanted electrodes to specific targets in the brain brain nuclei for the treatment of movement and neuropsychiatric disorders.Market Analysis and Insights Global Deep Brain Stimulation DBS Devices MarketDue to the COVID19 pandemic the global Deep Brain Stimulation DBS Devices market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-1B939
Wed Jan 26 00:00:00 UTC 2022

Add to Cart

Global Brain Aneurysm Clip Market Insights and Forecast to 2028
Global Brain Aneurysm Clip Market Insights and Forecast to 2028

Brain aneurysm clipping is performed to block off an intact aneurysm from the blood vessels to prevent any further leaking of blood from the site in the brain.Market Analysis and Insights Global Brain Aneurysm Clip MarketDue to the COVID19 pandemic the global Brain Aneurysm Clip market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-21P8542
Mon Jan 24 00:00:00 UTC 2022

Add to Cart

Global Ropinirole Market Insights and Forecast to 2028
Global Ropinirole Market Insights and Forecast to 2028

Ropinirole is also used to treat restless legs syndrome RLS.Market Analysis and Insights Global Ropinirole MarketDue to the COVID19 pandemic the global Ropinirole market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-21O8545
Mon Jan 24 00:00:00 UTC 2022

Add to Cart

Global Learning Disability Treatment Market Insights and Forecast to 2028
Global Learning Disability Treatment Market Insights and Forecast to 2028

Market Analysis and Insights Global Learning Disability Treatment MarketThe global Learning Disability Treatment market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Stimulants accounting for of the Learning Disabilit.

120 Pages
Type: Report
Code: QYRE-Auto-9K1240
Mon Jan 24 00:00:00 UTC 2022

Add to Cart